Hideki Takeda
Fortune : 1 M $ au 31/08/2026
Fortune : 1 M $ au 31/08/2026
Hideki Takeda is the founder of Scent Science International, Inc. He is currently an Independent Outside Director at Modalis Therapeutics Corp., a Representative Director at Medical Patent Research, Inc., an Outside Director at Ctex Co. Ltd., and a Director at Liid Pharmaceuticals, Inc. He received his undergraduate and graduate degrees from Osaka University.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
PRISM BioLab Co., Ltd.
PRISM BioLab Co., Ltd. BiotechnologyHealth Technology Provides drug discovery and development services using proprietary platform technology 2,53 % | 31/03/2026 | 935 000 ( 2,53 % ) | 1 M $ | 31/08/2026 |
| 31/12/2025 | 196 000 ( 0,19 % ) | 41 730 $ | 31/08/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| MODALIS THERAPEUTICS CORPORATION | Directeur/Membre du Conseil | 01/01/2016 |
Medical Patent Research, Inc. | Directeur/Membre du Conseil | 01/01/2009 |
Ctex Co. Ltd. | Directeur/Membre du Conseil | 01/02/2018 |
Scent Science International, Inc.
Scent Science International, Inc. Industrial ConglomeratesProducer Manufacturing Develops animal repellant | Fondateur | 23/07/2010 |
Liid Pharmaceuticals, Inc. | Directeur/Membre du Conseil | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 6 |
|---|---|
Osaka University
Osaka University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Scent Science International, Inc.
Scent Science International, Inc. Industrial ConglomeratesProducer Manufacturing Develops animal repellant | Producer Manufacturing |
Modalis Therapeutics Corp.
Modalis Therapeutics Corp. BiotechnologyHealth Technology Develops transformative therapeutics for diseases which are caused by malfunctioning of genes | Health Technology |
Medical Patent Research, Inc. | |
Ctex Co. Ltd. | |
Liid Pharmaceuticals, Inc. |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national